Literature DB >> 23489879

Ridge-related reentry: a variant of perimitral atrial tachycardia.

Seiji Takatsuki1, Kotaro Fukumoto, Osamu Igawa, Takehiro Kimura, Nobuhiro Nishiyama, Yoshiyasu Aizawa, Yoko Tanimoto, Kojiro Tanimoto, Shunichiro Miyoshi, Keiichi Fukuda.   

Abstract

INTRODUCTION: The ridge between the left pulmonary veins (PV) and the left atrial appendage composes part of the lateral mitral isthmus (LMI). Following circumferential PV isolation and LMI linear ablation for the treatment of atrial fibrillation (AF), a critical pathway might develop over the ridge leading to a ridge-related reentry (RRR). METHODS AND
RESULTS: Out of 61 patients who underwent circumferential PV isolation appended by LMI ablation, 5 patients developed RRR. The diagnosis of RRR was based on (1) macro-reentrant atrial tachycardia involving the septum, anterior and inferior wall of the left atrium; (2) slow conduction along the ridge; (3) wide-split double potentials in the ventricular aspect of the LMI were identified with the coronary sinus (CS) electrodes. RRR was investigated with electroanatomical mapping and entrainment mapping and catheter ablation was carried out in all patients. The mean cycle length (CL) of RRR was 312 ± 82 milliseconds and the PPIs at the left atrial septum, inferior and anterior wall during RRR were 10 ± 6, 12 ± 8, 9 ± 5 milliseconds longer than the RRR CL. The interval of the double potentials recorded in the CS electrodes crossing the LMI was 164 ± 38 milliseconds during RRR and the PPI on the LMI near the mitral annulus was 57 ± 10 milliseconds longer than the RRR CL. Catheter ablation was performed anatomically by targeting the ridge and successfully terminated RRR.
CONCLUSION: After circumferential PV isolation and ablation for LMI in patients with AF, RRR can develop by utilizing the surviving myocardial tissue of the ridge as a critical pathway.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  atrial fibrillation; catheter ablation; left atrial flutter; left atrial tachycardia; pulmonary vein isolation

Mesh:

Year:  2013        PMID: 23489879     DOI: 10.1111/jce.12120

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  5 in total

1.  Isolation of the conduction between the Marshall bundle and distal coronary sinus and the entire coronary sinus for an atrial tachycardia after catheter ablation of atrial fibrillation.

Authors:  Daisuke Wakatsuki; Taku Asano; Hiroshi Mase; Masaaki Kurata; Hisa Shimojima; Hiroshi Suzuki
Journal:  HeartRhythm Case Rep       Date:  2017-06-03

2.  Pseudo-conduction block at the mitral isthmus in a patient with epicardial impulse propagation through the vein of Marshall.

Authors:  Rintaro Hojo; Seiji Fukamizu; Takeshi Kitamura; Kenichi Maeno; Masayasu Hiraoka; Harumizu Sakurada
Journal:  HeartRhythm Case Rep       Date:  2015-04-15

3.  Sustained localized reentry within the left atrial appendage as a mechanism of recurrent arrhythmia following atrial fibrillation ablation.

Authors:  Jin-Cun Guo; Wei-Bin Huang; Fa-Guang Zhou; Jiang Hong; Yan Wang
Journal:  Exp Ther Med       Date:  2018-05-31       Impact factor: 2.447

4.  Incidence, electrophysiological characteristics, and long-term follow-up of perimitral atrial flutter in patients with previously confirmed mitral isthmus block.

Authors:  Panagiotis Ioannidis; Evangelia Christoforatou; Theodoros Zografos; Panagiotis Charalambopoulos; Konstantinos Kouvelas; Georgios Christoulas; Periklis Syros; Georgios Tsitsinakis; Theodora Kappou; Andreas Tsoumeleas; Sotirios Floros; Dimitrios Tagoulis; Ioannis Ntarladimas; Ioannis Tagoulis; Dimitrios Avzotis; Antonis S Manolis; Charalambos Vassilopoulos
Journal:  J Arrhythm       Date:  2021-05-12

5.  High-Resolution Mapping and Ablation of Atrial Tachycardias Involving the Lateral Left Atrium.

Authors:  Shinsuke Miyazaki; Kanae Hasegawa; Kazuya Yamao; Moe Mukai; Daisetsu Aoyama; Takayuki Sekihara; Minoru Nodera; Tomoya Eguchi; Yoshito Iesaka; Hiroshi Tada
Journal:  J Am Heart Assoc       Date:  2021-09-28       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.